{"meta":{"query_hash":"4104b9784c24","filters":{"venue":"Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4104b9784c24","api":"https://metacan.xera.ac/api/v1/cohort?venue=Ernst+Schering+Research+Foundation+workshop%2FErnst+Schering+Foundation+Symposium+proceedings"},"results":[{"id":"W1592175547","doi":"10.1007/2789_2006_021","title":"Preclinical Characterization of Selective Estrogen Receptor β Agonists: New Insights into Their Therapeutic Potential","year":2007,"lang":"en","type":"review","venue":"Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Estrogen receptor; Pharmacology; Selective estrogen receptor modulator; Chemistry; Computational biology; Medicine; Biology; Internal medicine; Breast cancer","score_opus":0.0731801057200819,"score_gpt":0.3941631989550063,"score_spread":0.32098309323492435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1592175547","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015113396,0.99341315,0.0012567255,0.0005945314,0.00027303945,0.00003518112,0.000113430004,0.000030118827,0.0027724295],"genre_scores_gemma":[0.0046386193,0.9915187,0.0010166296,0.00064694905,0.0001583377,0.000038014787,0.0002122852,0.000008386175,0.0017621289],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975413,0.000046550682,0.00002581337,0.00004473966,0.00009562417,0.000033161683],"domain_scores_gemma":[0.99947125,0.00024560234,0.00007793055,0.000022648692,0.00013969318,0.00004292723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013404194,0.0012077861,0.001701392,0.0012761822,0.00019225884,0.0012509568,0.0013552791,0.0011240499,0.0033777647],"category_scores_gemma":[0.0010917136,0.0003565348,0.0005393753,0.0011192838,0.00060430693,0.0011801854,0.0003968611,0.0021672854,0.0024128407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045738992,0.00036479416,0.000281911,0.0077035166,0.00008118502,0.00042193552,0.000058932987,0.0010091779,0.033345405,0.003826158,0.029309059,0.9231407],"study_design_scores_gemma":[0.00023205727,0.0010843417,0.001314396,0.0012569891,0.00021105008,0.0022712396,0.00006996468,0.00024715468,0.017454002,0.0018938888,0.9739274,0.000037481834],"about_ca_topic_score_codex":0.0010809303,"about_ca_topic_score_gemma":0.0020003924,"teacher_disagreement_score":0.0033777647,"about_ca_system_score_codex":0.00090739276,"about_ca_system_score_gemma":0.0012545736,"threshold_uncertainty_score":0.011299729},"labels":[],"label_agreement":null},{"id":"W78156908","doi":"10.1007/2789_2008_089","title":"Using Metabolomics to Monitor Anticancer Drugs","year":2008,"lang":"en","type":"review","venue":"Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"In vivo; Context (archaeology); Drug; Pharmacology; Metabolome; Pharmacodynamics; Drug action; Drug development; Cancer; Ex vivo; Medicine; Chemistry; Metabolomics; Bioinformatics; Biology; Pharmacokinetics; Internal medicine; Biotechnology","score_opus":0.13545041359836682,"score_gpt":0.4303036436588048,"score_spread":0.29485323006043795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W78156908","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031942033,0.9937749,0.0018889336,0.00088168203,0.0007366856,0.0000134845195,0.000057770445,0.00005915702,0.0022679593],"genre_scores_gemma":[0.0026581117,0.98954016,0.0019597127,0.0008052253,0.00065812893,0.000031227955,0.00009539802,0.000007962153,0.004244032],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997521,0.000034463887,0.000015416113,0.00005227314,0.00012704851,0.000018712866],"domain_scores_gemma":[0.99977046,0.00009813216,0.000026591712,0.0000113530805,0.00007716215,0.000016403785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065509917,0.0014990689,0.001375084,0.0020972865,0.00018417016,0.0009157678,0.0008117739,0.0014107891,0.0022480835],"category_scores_gemma":[0.00062308327,0.0003481924,0.0005586956,0.001766663,0.00045182958,0.0010388097,0.0006906807,0.0013496676,0.0029998873],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013976297,0.00008765022,0.00018977262,0.0030462812,0.000092452065,0.00016842177,0.000013268639,0.00024930583,0.017066307,0.0016286414,0.030951448,0.9463667],"study_design_scores_gemma":[0.00006566231,0.00023055235,0.0019719915,0.00089237356,0.00020126709,0.0016727427,0.000042315525,0.0005983935,0.023430523,0.0028541523,0.96798795,0.00005201911],"about_ca_topic_score_codex":0.00081971724,"about_ca_topic_score_gemma":0.0015888467,"teacher_disagreement_score":0.0022480835,"about_ca_system_score_codex":0.0006106566,"about_ca_system_score_gemma":0.0004237353,"threshold_uncertainty_score":0.0075205564},"labels":[],"label_agreement":null},{"id":"W94777087","doi":"10.1007/2789_2008_078","title":"In Vitro and In Vivo Characterization of a Novel Nonsteroidal, Species-Specific Progesterone Receptor Modulator, PRA-910","year":2008,"lang":"en","type":"article","venue":"Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"National Center for Research Resources","keywords":"Progesterone receptor; Agonist; Endocrinology; Internal medicine; Receptor; Mifepristone; Chemistry; Partial agonist; Antagonist; In vivo; IC50; Estrogen receptor; Biology; In vitro; Medicine; Biochemistry; Cancer","score_opus":0.04187036155644928,"score_gpt":0.29907764633166206,"score_spread":0.25720728477521276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W94777087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732233,0.009799007,0.010292916,0.00034662758,0.000113958544,0.00014530995,0.0009290387,0.000104275474,0.0050454848],"genre_scores_gemma":[0.9612661,0.007387448,0.011134016,0.00025488666,0.000079619116,0.00011535498,0.005274463,0.000074690535,0.014413407],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99987316,0.00003095466,0.000009281111,0.000025276793,0.00002927298,0.000031926636],"domain_scores_gemma":[0.99985266,0.000051144423,0.000020870366,0.000019783687,0.000022260885,0.00003320397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000323148,0.00039249164,0.0002907956,0.00021065214,0.00020880305,0.00031971434,0.00024875038,0.00023639623,0.002190684],"category_scores_gemma":[0.0003019195,0.00022686073,0.00032763585,0.00015958062,0.0002258593,0.00026784494,0.00013296724,0.00058863993,0.0010390175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019745286,0.000033259148,0.000051769024,0.000021332638,0.000004352416,0.000033185202,0.000012260378,0.00004597258,0.9982083,0.000044360822,0.000042908083,0.0013048566],"study_design_scores_gemma":[0.000056390647,0.0016710125,0.0016344306,0.000004456676,0.000038420803,0.00052304915,0.000030568208,0.00037260517,0.98898774,0.000038155602,0.0066386596,0.000004544364],"about_ca_topic_score_codex":0.0007766615,"about_ca_topic_score_gemma":0.00124078,"teacher_disagreement_score":0.002190684,"about_ca_system_score_codex":0.00024814703,"about_ca_system_score_gemma":0.00033418936,"threshold_uncertainty_score":0.00732857},"labels":[],"label_agreement":null}]}